(TSX:ISC), Solid Q2 2025 performance from diversified segments. Registry Operations stable, Services saw growth in Recovery Solutions, Technology Solutions improved efficiency. Financial discipline maintained, ensuring sustained performance. Capitalized terms that are used but not defined in this news release have the meaning ascribed to those terms in Management's Discussion & Analysis for the three and […]
ISC Reports Financial Results for the Second Quarter of 2025 GlobeNewswire July 31, 2025 Solid Q2 2025 performance from diversified segments. Registry Operations stable, Services saw growth in Recovery Solutions, Technology Solutions improved efficiency. Financial discipline maintained, ensuring sustained performance. Capitalized terms that are used but not defined in this news release have the meaning
(TSX:ISC), REGINA, Saskatchewan, July 30, 2025 (GLOBE NEWSWIRE) — The Board of Directors of Information Services Corporation (TSX:ISC) (“ISC” or the “Company”) today declared a quarterly cash dividend of $0.23 per Class A Limited Voting Share (“Class A Share”). The dividend will be paid on or before October 15, 2025 to shareholders of record as
ISC Declares Quarterly Dividend GlobeNewswire July 31, 2025 REGINA, Saskatchewan, July 30, 2025 (GLOBE NEWSWIRE) — The Board of Directors of Information Services Corporation (TSX:ISC) (“ISC” or the “Company”) today declared a quarterly cash dividend of $0.23 per Class A Limited Voting Share (“Class A Share”). The dividend will be paid on or before October
(CNSX:RVV.CN),(CNSX:RVV),(OTC US:RVVTF),(Other OTC:RVVTF),(Frankfurt:31R), TORONTO, July 30, 2025 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing innovative therapeutics for critical medical needs, announces that it is proposing to arrange a private placement offering of up to 30,952,381 units, at a
Revive Therapeutics Announces Proposed Private Placement and Debt Settlement GlobeNewswire July 31, 2025 TORONTO, July 30, 2025 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing innovative therapeutics for critical medical needs, announces that it is proposing to arrange a
NEW YORK, NY / ACCESS Newswire / July 30, 2025 / If you suffered a loss on your Biohaven Ltd. (NYSE:BHVN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/biohaven-ltd-lawsuit-submission-form?prid=158963&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
35 Years of Research Suggests Raptor Competition Risks WASHINGTON, DC / ACCESS Newswire / July 30, 2025 / The following report was written by Saving Seafood: The Chesapeake Bay is once again teeming with bald eagles, a testament to decades of successful conservation efforts. A recent feature by the Maryland Department of Natural Resources (DNR),
(NASDAQ:MQ), NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Marqeta, Inc. (NASDAQ:MQ) on behalf of long-term stockholders following a class action complaint that was filed against Marqeta on December 9, 2024 with a Class Period from May 7,
MARQETA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Marqeta, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm GlobeNewswire July 31, 2025 NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Marqeta, Inc.